Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2571060, 11 pages
http://dx.doi.org/10.1155/2016/2571060
Research Article

Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model

1Department of Anaesthesiology, Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China
2Department of Gastrointestinal Surgery, Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China
3Department of Spine Surgery, Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China
4Department of Laboratory, Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong 519000, China

Received 9 April 2016; Accepted 10 July 2016

Academic Editor: Sanjula Baboota

Copyright © 2016 Xiao-Yu Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray and A. D. Lopez, “Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study,” The Lancet, vol. 349, no. 9063, pp. 1436–1442, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Candelario-Jalil, N. H. Mhadu, S. M. Al-Dalain, G. Martínez, and O. S. León, “Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils,” Neuroscience Research, vol. 41, no. 3, pp. 233–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Schaller and R. Graf, “Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy,” Journal of Cerebral Blood Flow & Metabolism, vol. 24, no. 4, pp. 351–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Bromont, C. Marie, and J. Bralet, “Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats,” Stroke, vol. 20, no. 7, pp. 918–924, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Al-Majed, F. A. Al-Omar, and M. N. Nagi, “Neuroprotective effects of thymoquinone against transient forebrain ischemia in the rat hippocampus,” European Journal of Pharmacology, vol. 543, no. 1–3, pp. 40–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Kanter, “Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats,” Neurochemical Research, vol. 33, no. 3, pp. 579–588, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. W. M. Pardridge, “The blood-brain barrier: bottleneck in brain drug development,” NeuroRx, vol. 2, no. 1, pp. 3–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Pires, A. Fortuna, G. Alves, and A. Falcão, “Intranasal drug delivery: how, why and what for?” Journal of Pharmacy and Pharmaceutical Sciences, vol. 12, no. 3, pp. 288–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Illum, “Transport of drugs from the nasal cavity to the central nervous system,” European Journal of Pharmaceutical Sciences, vol. 11, no. 1, pp. 1–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kumar, A. Misra, A. K. Babbar, A. K. Mishra, P. Mishra, and K. Pathak, “Intranasal nanoemulsion based brain targeting drug delivery system of risperidone,” International Journal of Pharmaceutics, vol. 358, no. 1-2, pp. 285–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Haque, S. Md, M. Fazil et al., “Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation,” Carbohydrate Polymers, vol. 89, no. 1, pp. 72–79, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, P. Li, and L. Kong, “Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery,” AAPS PharmSciTech, vol. 14, no. 2, pp. 585–592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. O. A. Ghosheh, A. A. Houdi, and P. A. Crooks, “High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.),” Journal of Pharmaceutical and Biomedical Analysis, vol. 19, no. 5, pp. 757–762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yin, D. Chen, M. Qiao, Z. Lu, and H. Hu, “Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin,” Journal of Controlled Release, vol. 116, no. 3, pp. 337–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Durukan and T. Tatlisumak, “Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia,” Pharmacology Biochemistry and Behavior, vol. 87, no. 1, pp. 179–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. B. Bederson, L. H. Pitts, S. M. Germano, M. C. Nishimura, R. L. Davis, and H. M. Bartkowski, “Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats,” Stroke, vol. 17, no. 6, pp. 1304–1308, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Akhtar, A. M. Maikiyo, A. K. Najmi, R. Khanam, M. Mujeeb, and M. Aqil, “Neuroprotective effects of chloroform and petroleum ether extracts of Nigella sativa seeds in stroke model of rat,” Journal of Pharmacy and Bioallied Sciences, vol. 5, no. 2, pp. 119–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Akhtar, A. M. Maikiyo, R. Khanam, M. Mujeeb, M. Aqil, and A. K. Najmi, “Ameliorating effects of two extracts of Nigella sativa in middle cerebral artery occluded rat,” Journal of Pharmacy and Bioallied Sciences, vol. 4, no. 1, pp. 70–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  21. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Greenworld, CRC Handbook of Methods for Oxygen Radical Research, CRC Press, Boca Raton, Fla, USA, 1985.
  24. T. Kagiyama, S. Kagiyama, and M. I. Phillips, “Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats,” Regulatory Peptides, vol. 110, no. 3, pp. 241–247, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Tosi, L. Costantino, F. Rivasi et al., “Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123,” Journal of Controlled Release, vol. 122, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Mustafa, A. Ahuja, A. H. Al Rohaimi et al., “Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization,” Expert Review of Neurotherapeutics, vol. 15, no. 6, pp. 695–710, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Rahman, “Studies on free radicals, antioxidants, and co-factors,” Clinical Interventions in Aging, vol. 2, no. 2, pp. 219–236, 2007. View at Google Scholar · View at Scopus
  28. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M.-J. R. Howes and P. J. Houghton, “Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 513–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. Alkharfy, A. Ahmad, R. M. A. Khan, and W. M. Al-Shagha, “Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 40, no. 3, pp. 319–323, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Joachim, I.-D. Kim, Y. Jin, K. Kim, J.-K. Lee, and H. Choi, “Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model,” Drug Delivery and Translational Research, vol. 4, no. 5-6, pp. 395–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Ahmad, S. Umar, M. Ashafaq et al., “A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke,” Protoplasma, vol. 250, no. 6, pp. 1327–1338, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zhao, R. Jin, W. Yang et al., “Using gelatin nanoparticle mediated intranasal delivery of neuropeptide substance P to enhance neuro-recovery in hemiparkinsonian rats,” PLOS ONE, vol. 11, no. 2, Article ID e0148848, 2016. View at Publisher · View at Google Scholar
  34. N. Nagai, C. Yoshioka, Y. Ito, Y. Funakami, H. Nishikawa, and A. Kawabata, “Intravenous administration of cilostazol nanoparticles ameliorates acute ischemic stroke in a cerebral ischemia/reperfusion-induced injury model,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 29329–29344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. El Mezayen, M. El Gazzar, M. R. Nicolls, J. C. Marecki, S. C. Dreskin, and H. Nomiyama, “Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation,” Immunology Letters, vol. 106, no. 1, pp. 72–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Dyer, M. Hinchcliffe, P. Watts et al., “Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles,” Pharmaceutical Research, vol. 19, no. 7, pp. 998–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus